Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikhil Amin

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Diabetes Care|August 9, 2015
Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes AgentsJulio Rosenstock, Denise Franco, Vadym Korpachev, et al.
The Laryngoscope|August 26, 2021
Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal PolypsAsif H Khan, Matthew Reaney, Isabelle Guillemin, et al.
The Laryngoscope|November 23, 2020
The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in JapanShigeharu Fujieda, Shoji Matsune, Sachio Takeno, et al.
The Laryngoscope|February 6, 2019
Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polypsNeil Bhattacharyya, Sara Villeneuve, Vijay N Joish, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
ATP8B1-TMEM30B Flippase Activity Maintains Stereocilia Lipid Asymmetry Required for HearingHenry N De Hoyos, Sihan Li, Jun-Sub Im, et al.
The Laryngoscope|August 30, 2025
Effectiveness and Safety of Dupilumab Monotherapy in Japanese Patients With Chronic Rhinosinusitis With Nasal PolypsShigeharu Fujieda, Tetsuji Takabayashi, Nobuo Ohta, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2024
Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumabKaitlyn Gayvert, Martin Desrosiers, Tanya M Laidlaw, et al.
Allergy|January 16, 2022
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studiesStella E Lee, Claire Hopkins, Joaquim Mullol, et al.
The Journal of Allergy and Clinical Immunology|January 23, 2018
Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthmaSteven F Weinstein, Rohit Katial, Shyamalie Jayawardena, et al.
Patient Preference and Adherence|December 1, 2021
Data Mining of Free-Text Responses: An Innovative Approach to Analyzing Patient Perspectives on Treatment for Chronic Rhinosinusitis with Nasal Polyps in a Phase IIa Proof-of-Concept Study for DupilumabAsif H Khan, Adeline Abbe, Bruno Falissard, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Diabetes Care|August 9, 2015
Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes AgentsJulio Rosenstock, Denise Franco, Vadym Korpachev, et al.
The Laryngoscope|August 26, 2021
Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal PolypsAsif H Khan, Matthew Reaney, Isabelle Guillemin, et al.
The Laryngoscope|November 23, 2020
The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in JapanShigeharu Fujieda, Shoji Matsune, Sachio Takeno, et al.
The Laryngoscope|February 6, 2019
Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polypsNeil Bhattacharyya, Sara Villeneuve, Vijay N Joish, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
ATP8B1-TMEM30B Flippase Activity Maintains Stereocilia Lipid Asymmetry Required for HearingHenry N De Hoyos, Sihan Li, Jun-Sub Im, et al.
The Laryngoscope|August 30, 2025
Effectiveness and Safety of Dupilumab Monotherapy in Japanese Patients With Chronic Rhinosinusitis With Nasal PolypsShigeharu Fujieda, Tetsuji Takabayashi, Nobuo Ohta, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2024
Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumabKaitlyn Gayvert, Martin Desrosiers, Tanya M Laidlaw, et al.
Allergy|January 16, 2022
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studiesStella E Lee, Claire Hopkins, Joaquim Mullol, et al.
The Journal of Allergy and Clinical Immunology|January 23, 2018
Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthmaSteven F Weinstein, Rohit Katial, Shyamalie Jayawardena, et al.
Patient Preference and Adherence|December 1, 2021
Data Mining of Free-Text Responses: An Innovative Approach to Analyzing Patient Perspectives on Treatment for Chronic Rhinosinusitis with Nasal Polyps in a Phase IIa Proof-of-Concept Study for DupilumabAsif H Khan, Adeline Abbe, Bruno Falissard, et al.
Pageof 6